Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment.

Barrett J.

Curr Opin Immunol. 2006 Oct;18(5):592-8. Epub 2006 Jul 26. Review.

PMID:
16872820
3.

Reconstructing immunity after allogeneic transplantation.

Giver CR, Li JM, Hossain MS, Lonial S, Waller EK.

Immunol Res. 2004;29(1-3):269-82. Review.

PMID:
15181288
4.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28.

PMID:
18573173
5.

Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

Sprangers B, Fevery S, Van Wijmeersch B, De Somer L, Waer M, Billiau AD.

Front Biosci. 2007 May 1;12:4568-94.

PMID:
17485398
6.

[Immunologic reconstitution after allogeneic stem cell transplant].

Lacerda JF.

Acta Med Port. 2004 Nov-Dec;17(6):471-80. Epub 2005 Jan 18. Review. Portuguese.

7.

Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells.

Fowler DH, Bishop MR, Gress RE.

Semin Oncol. 2004 Feb;31(1):56-67. Review.

PMID:
14970938
8.
9.

The history and future prospective of haplo-identical stem cell transplantation.

Handgretinger R, Lang P.

Cytotherapy. 2008;10(5):443-51. doi: 10.1080/14653240802251507. Review.

PMID:
18615344
10.

New developments in allotransplant immunology.

Barrett AJ, Rezvani K, Solomon S, Dickinson AM, Wang XN, Stark G, Cullup H, Jarvis M, Middleton PG, Chao N.

Hematology Am Soc Hematol Educ Program. 2003:350-71. Review.

PMID:
14633790
11.

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.

Ciceri F, Bonini C, Gallo-Stampino C, Bordignon C.

Cytotherapy. 2005;7(2):144-9. Review.

PMID:
16040393
12.

Selective depletion strategies in allogeneic stem cell transplantation.

Mielke S, Solomon SR, Barrett AJ.

Cytotherapy. 2005;7(2):109-15. Review.

PMID:
16040390
14.

Cytolytic pathways in haematopoietic stem-cell transplantation.

van den Brink MR, Burakoff SJ.

Nat Rev Immunol. 2002 Apr;2(4):273-81. Review.

PMID:
12001998
15.

Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.

André-Schmutz I, Dal Cortivo L, Fischer A, Cavazzana-Calvo M.

Cytotherapy. 2005;7(2):102-8. Review.

PMID:
16040389
16.

Immune reconstitution following stem cell transplantation.

Peggs KS.

Leuk Lymphoma. 2004 Jun;45(6):1093-101. Review.

PMID:
15359987
17.

Current status of haploidentical stem cell transplantation.

Dey BR, Spitzer TR.

Br J Haematol. 2006 Nov;135(4):423-37. Epub 2006 Sep 19. Review.

PMID:
16984391
18.

Immunotherapy by allogeneic stem cell transplantation.

Ringdén O.

Adv Cancer Res. 2007;97:25-60. Review.

PMID:
17419940
19.

Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.

Robinet E, Fehse B, Ebeling S, Sauce D, Ferrand C, Tiberghien P.

Cytotherapy. 2005;7(2):150-7. Review.

PMID:
16040394
20.

Exploiting beneficial alloreactive T cells.

Barber LD, Madrigal JA.

Vox Sang. 2006 Jul;91(1):20-7. Review.

PMID:
16756597

Supplemental Content

Support Center